Cancer Neuroscience Symposium 2024

---

LIVE

Wednesday, February 28, 2024, 1:00 PM - Friday, March 1, 2024, 4:00 PM, MD Anderson, Houston, TX

MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes.

This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring together leading experts from across the fields of neuroscience, cancer biology, immunology, and the biology of aging, as well as oncologists, surgeons, neurologists, patients and patient advocates to facilitate discussions of exciting new concepts and developments in this rapidly growing field.

CNS 2024: Satellite Meeting on Clinical Cancer Neuroscience

The 2024 Satellite Meeting of the Cancer Neuroscience Symposium will be held virtually on February 28, 2024. Talks will present translational and clinical innovations in cancer neuroscience. Speakers will discuss advances in neurotoxicities during cancer therapies, mental health and pain effects from cancer and cancer therapies, a clinical trial panel, and a meet the editor session.  The satellite meeting aims to cross-fertilize the breadth of cancer neuroscience presented at the primary cancer neuroscience symposium.

Click ABSTRACTS to See Instructions

ABSTRACTS

1. Summarize interactions between cancer and the nervous system;
2. Discuss neuro-cancer crosstalk (mediators, mechanisms, and outcomes) in the central and peripheral nervous systems;
3. Understand neurotoxicities and nervous system health during cancer therapy; and
4. Describe novel concepts in targeting neuro-immune crosstalk in the central and peripheral nervous systems and their translational impact.

The Cancer Neuroscience Symposium 2024 Registration is Now Open!  Register soon, there are only 240 in person seats available each day! The Symposium will begin at 7:30 AM on Thursday February 29, 2024 and will adjourn at 4:00 PM on Friday, March 1, 2024.  Advanced registration is encouraged please see registration information below for applicable fees.

Day 1
Sessions will delve into novel findings in fundamental research of the nervous system and cancer biology.  We will highlight our special focus on the interaction of cancer and aging biology, including neurodegeneration. Attendees should gain insights into fundamental research that addresses contributing and causative factors that can hijack or hamper these basic biological processes.

Speakers: Michelle Monje-Deisseroth, Elizabeth A. Repasky, Frank Winkler, Gustavo Ayala, Brian Davis, Moran Amit, Monty Montano, and Preoffered abstracts
Focus Area Speakers: Shane Liddelow, Jorg Dietrich, Benjamin Deneen, Derek Wainwright

Day 2
Breakout Symposium: Central Nervous System
This session will examine current findings into the interplay between the central nervous system and cancer biology. The CNS Breakout Symposium features 5 breakout sessions:
1) Neuronal Regulation of Primary CNS Cancer; 2) Neuronal Regulation of CNS Metastasis; 3) Influence of CNS Cancer on Neuronal Activity; 4) Cancer Therapy Induced CNS Impairments; and 5) Modeling Brain Tumor and TME Interactions.
Attendees should gain insights into fundamental research that addresses contributing and causative factors that can hijack or hamper these basic biological findings.

Speakers: Varun Venkataramani, David Gutmann, Kathryn Taylor, Adrienne Boire, Humsa Venkatesh, Manuel Valiente, Shawn Hervey-Jumper, Harald Sontheimer, Erin Gibson, Munjal Acharya, Donald Mabbott, Joshua Breunig, Hui Zong, Suzanne Baker, Vinay Puduvalli, and Yuan Pan.

Breakout Symposium: Peripheral Nervous System
This session will examine current foundational research findings into the interactions between peripheral nerves and tumors. Speakers will discuss
1) The Interactions and Impact of Nerves on Cancer, Stromal and Immune Cells, and 2) The Role of Tumor Cells in Facilitating the Recruitment and Function of Peripheral Neural, Glial and Immune Cells that in Turn Modulate Cancer Progression and Outcomes.
Attendees should gain insights into the cellular interactions in the neural tumor microenvironment that drive cancer growth and progression in peripheral tumors.

Speakers: Paola Vermeer, Rohini Kuner, William Hwang, Yuri Bunimovich, Sébastien Talbot, Jami Saloman, Fanny Mann, Nicole Scheff, Richard Wong, Timothy Wang, Faranak Fattahi, Ruth White, Moran Amit, Ekin Demir and Nisha D’Silva.

After the Cancer Neuroscience Symposium, we hope that you can easily see how multidimensional and interdisciplinary efforts will integrate and cross- fertilize these themes toward larger aspirational goals.

Registration Fees: 

The Cancer Neuroscience Symposium is a two-day hybrid symposium, on-site and virtual options, presented by The University of Texas MD Anderson Cancer Center. Registration for on-site participation is limited to 240 seats and the subsided in-person registration fee is $90 for early bird, and $150 thereafter.

We understand that everyone's financial situation is different, and we want to ensure that cost is not a barrier to participating in this incredible event. With our "Pay As You Wish" virtual registration option, you are able to choose the virtual registration fee that best fits your budget. Whatever dollar amount you wish to contribute, the decision is entirely up to you. We appreciate any amount that you can offer, as it helps support the symposium and it enables us to continue planning enriching educational experiences for all attendees.

Please select the registration fee that is appropriate for you.

Pay As You Wish Fee Structure (Virtual)

1. Pay As You Wish - $0.00
2. Pay As You Wish - $48.00
3. Pay As You Wish - $96.00
4. Pay As You Wish - $148.00
5. Pay As You Wish - $199.00

On-Site Registration (In Person) (Limited Seating) Only 240 seats available

1. In Person Attendance Fee - $90.00 (Before October 1, 2023)
2. In Person Attendance Fee - $150.00 (After October 1, 2023)

CNS 2024: Satellite Meeting on Clinical Cancer Neuroscience - February 28, 2024, Wednesday @ 1:00 - 4:30 p.m. (Optional)

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)
• Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation email) will be automatically emailed to the e-mail address you list on the registration form.

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $15 administration-handling fee, is refundable if a written request is received on or before February 16, 2024. No refunds will be granted after this date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone number given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee.

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information or for Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

 

Planning Committee

Moran Amit, MD, PhD Conference Chair UT MD Anderson Cancer Center Brandi Mattson, PhD Organizing Committee Chair UT MD Anderson Cancer Center Monty Montano, PhD Organizing Committee Chair Harvard Medical School Brigham and Women’s Hospital

Nisha D'Silva, BDS, MSD, PhD Professor University of Michigan School of Dentistry Ekin Demir, MD Technical University of Munich  William L. Hwang, MD, PhD Assistant Professor Harvard Medical School/Massachusetts General Hospital

Yuan Pan, PhD Assistant Professor UT MD Anderson Cancer Center Vinay Puduvalli, MD Professor UT MD Anderson Cancer Center Nicole Scheff, PhD Assistant Professor University of Pittsburgh

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

W9 Form Exhibit at this Event